Danube Pharmaceuticals Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2007
NCT00683501
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Alternative names

CEO, CMO, Danube Pharmaceuticals, Inc. | Danube Pharmaceuticals, Inc.